Gynesonics Announces New York Medicaid Coverage for CPT Code 58580, Transcervical Radio Frequency Ablation of Uterine Fibroids
December 17, 2024 09:00 ET
|
Gynesonics
REDWOOD CITY, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gynesonics Inc., a medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is...
Gynesonics Announces New SMART OS™ Software Technology for Sonata® System Treatment of Uterine Fibroids
September 26, 2024 08:30 ET
|
Gynesonics
REDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Gynesonics Inc., a medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids,...
Gynesonics® Reaches Milestone with 10,000th Patient Treatment with Sonata System
August 20, 2024 10:30 ET
|
Gynesonics
REDWOOD CITY, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for...
Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment
March 19, 2024 10:00 ET
|
Gynesonics
Gynesonics announces key executive appointments to further accelerate and expand adoption of the Sonata Treatment.
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
January 02, 2024 11:13 ET
|
Gynesonics
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
November 02, 2023 09:41 ET
|
Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
CORRECTION – Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
November 01, 2023 20:08 ET
|
Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
November 01, 2023 16:00 ET
|
Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids Reaches Patient Milestones in the U.S. and Globally
October 25, 2023 16:07 ET
|
Gynesonics
Gynesonics is pleased to announce that its Sonata Procedure has been used to treat over 1,000 women in the United States in 2023
Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids Reaches Patient Milestones in the U.S. and Globally
October 17, 2023 12:00 ET
|
Gynesonics
Gynesonics' Sonata® Procedure has been used to treat over 1,000 women in the United States and approximately 6,500 women globally.